ReviewMolecular oncology2020
What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyond.
Review in Molecular oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- The value of community engagement in the ESTRO-EORTC OligoCare project: A quantification of the in-kind contributions.Clinical and translational radiation oncology · 2027Article
- DEGRO consensus framework for undergraduate radiation therapy teaching in Germany: a white paper with integrated guidance on artificial intelligence in medical education.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026Article
- Health economics evaluation of artificial intelligence in the field of oncology: a scoping review.Health economics review · 2026Review
- How I Do It: Interprofessional Education and Radiation Therapy-Establishing Opportunities for Student Learning in the Workplace.Journal of medical radiation sciences · 2025Article
- The impact of digital tools and the expected digital transformation in radiotherapy on Dutch radiation therapists (RTTs).Technical innovations & patient support in radiation oncology · 2025Article
- Detection of radiosensitive subpopulationsFrontiers in oncology · 2025Article
- Precision Metrics: A Narrative Review on Unlocking the Power of KPIs in Radiology for Enhanced Precision Medicine.Journal of personalized medicine · 2024Review
- Antioxidants Hydroxytyrosol and Thioredoxin-Mimetic Peptide CB3 Protect Irradiated Normal Tissue Cells.Antioxidants (Basel, Switzerland) · 2024Article
- Review
- Harnessing progress in radiotherapy for global cancer control.Nature cancer · 2023Review
- Evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for adjuvant radiotherapy in breast cancer.ESMO open · 2023Article
- Teaching in radiation oncology: now and 2025-results of a focus group with medical students.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2023Article
- Application of Gold Nanoparticles as Radiosensitizer for Metastatic Prostate Cancer Cell Lines.International journal of molecular sciences · 2023Article
- Gender-Oriented Mental Health Prevention: A Reappraisal.International journal of environmental research and public health · 2022Review
- Combining Nanocarrier-Assisted Delivery of Molecules and Radiotherapy.Pharmaceutics · 2022Review
- Towards a cancer mission in Horizon Europe: recommendations.Molecular oncology · 2020Article
- Radiation Oncology - Towards a mission-oriented approach to cancer.Molecular oncology · 2020Article
- Implementation of Health Systems Science Curriculum in Radiation Oncology Resident Education.Journal of medical education and curricular developmentArticle
- In Reply to Li et al.Advances in radiation oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The number of newly diagnosed cancers per year is predicted to almost double in the next two decades worldwide, and it remains unclear if and when this alarming trend will level off or even reverse. As such, cancer is very likely to continue to pose a major threat to human health. Radiation oncology is an indispensable pillar of cancer treatment and a well-developed discipline. Nevertheless, key trends in cancer research and care, including improved primary prevention, early detection, integrated multidisciplinary approaches, personalized strategies at all levels of care, value-based assessments of healthcare systems, and global health perspectives, will all shape the future of radiation oncology. Broader scientific advances, such as rapid progress in digitization, automation, and in our biological understanding of cancer, as well as the wider societal view of healthcare systems will also influence radiation oncology and how it is practiced. To stimulate a proactive discussion on how to adapt and reshape our discipline, this review provides some predictions on what the role and practice of radiation oncology might look like in 30 years' time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.